Article
VEGF-A165 augments erythropoietic development from human embryonic stem cells
9 Dec 2003
Abstract excerpt
Combinations of hematopoietic cytokines and the ventral mesoderm inducer BMP-4 have recently been shown to augment hematopoietic cell fate of human embryonic stem cells (hESCs) during embryoid body (EB) development. However, factors capable of regulating lineage commitment of hESC-derived hematopoiesis have yet to be reported. Here we show that vascular endothelial growth factor (VEGF-A165) selectively promotes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
